Craft

Haisco

Stock Price

¥35.7

2024-10-29

Market Capitalization

¥39.2 B

2024-10-29

Revenue

¥4.3 B

FY, 2025

Haisco Summary

Company Summary

Overview
Haisco Pharmaceutical Group (海思科医药集团) is a company that specializes in the areas of drug development, manufacturing, and sales. It is engaged in the development of parenteral nutrition drugs, antibiotics, anesthetic agents, nervous system drugs, digestive system medications, etc.
Type
Public
Status
Active
Founded
2000
Website
http://www.haisco.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Table of Contents

Haisco Financials

Summary Financials

Revenue (Q1, 2026)
¥1.5B
Gross profit (Q1, 2026)
¥1.3B
Net income (Q1, 2026)
¥554.6M
Cash (Q1, 2026)
¥1.8B
EBIT (Q1, 2026)
¥594.5M
Enterprise value
$39.6B

Footer menu